Raymond James & Associates’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$29.7M Buy
505,375
+94,689
+23% +$5.17M 0.02% 627
2024
Q2
$22.2M Sell
410,686
-102,757
-20% -$5.66M 0.01% 727
2024
Q1
$29.6M Buy
513,443
+145,615
+40% +$7.52M 0.02% 599
2023
Q4
$17.6M Sell
367,828
-28,559
-7% -$1.36M 0.01% 797
2023
Q3
$20.3M Sell
396,387
-1,330
-0.3% -$70.4K 0.02% 675
2023
Q2
$22.8M Sell
397,717
-78,402
-16% -$4.58M 0.02% 643
2023
Q1
$28.7M Sell
476,119
-96,087
-17% -$5.87M 0.02% 537
2022
Q4
$33.6M Sell
572,206
-57,187
-9% -$3.62M 0.03% 458
2022
Q3
$36M Buy
629,393
+35,339
+6% +$2.06M 0.04% 409
2022
Q2
$32.2M Sell
594,054
-37,028
-6% -$2.15M 0.03% 438
2022
Q1
$36.3M Buy
631,082
+124,211
+25% +$6.35M 0.03% 461
2021
Q4
$24M Buy
506,871
+8,393
+2% +$382K 0.02% 655
2021
Q3
$21M Sell
498,478
-29
-0% -$1.25K 0.02% 677
2021
Q2
$22.1M Sell
498,507
-12,782
-2% -$591K 0.02% 669
2021
Q1
$23.8M Buy
511,289
+93,982
+23% +$4.16M 0.02% 587
2020
Q4
$16.2M Buy
417,307
+17,675
+4% +$632K 0.02% 715
2020
Q3
$11.5M Sell
399,632
-211,658
-35% -$5.96M 0.01% 792
2020
Q2
$16.4M Sell
611,290
-17,238
-3% -$449K 0.02% 601
2020
Q1
$14.8M Sell
628,528
-80,913
-11% -$2.22M 0.02% 571
2019
Q4
$21M Buy
709,441
+220,127
+45% +$5.83M 0.03% 559
2019
Q3
$13.7M Sell
489,314
-168,519
-26% -$4.87M 0.02% 712
2019
Q2
$19.5M Buy
+657,833
New +$17.7M 0.03% 546

Other funds holding CTVA

Raymond James & Associates's CTVA Position: Q3 2024 in Review

Raymond James & Associates increased its Corteva (CTVA) stake by 23% in Q3 2024, buying an estimated $5.17M and bringing the position to 505,375 shares worth $29.7M. The position accounts for 0.02% of the portfolio, ranked #627.

Raymond James & Associates first reported a position in CTVA in Q2 2019 and has held it in 22 quarters since. The position peaked at $36.3M in Q1 2022. 1,228 funds tracked by Wall St. Rank hold CTVA as of Q3 2024.

  • Raymond James & Associates held 505,375 shares of Corteva worth $29.7M as of Q3 2024.
  • Raymond James & Associates bought 94,689 Corteva shares in Q3 2024, an estimated $5.17M.
  • Corteva made up 0.02% of Raymond James & Associates's portfolio in Q3 2024, its #627 holding.
  • Raymond James & Associates first reported a position in Corteva in Q2 2019 and has held it in 22 quarters since.
  • Raymond James & Associates's Corteva position peaked at $36.3M in Q1 2022.
  • 1,228 funds tracked by Wall St. Rank held Corteva as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.